Innovation Blog

Accelerate your breakthroughs with novel technologies.

Innovation Blog

Take 5: When Less Leads to More – Efficiency Elevates Scientists

Developing scientific products and bringing them to market is a herculean task, testing the limits of human ingenuity while also demanding an enormous amount of resources. Even so, scientists persevere when faced with these challenges because their achievements have the power to enrich human lives all over the world. With so much at stake, researchers need fewer roadblocks and greater opportunities. Their empowerment benefits us all.


Unsurprisingly, R&D costs billions of dollars and thousands of hours of work annually. These arduous requirements hinder growth and wear out scientists. Improving the efficiency of the R&D process would naturally have a huge impact in terms of cost and mindshare, leading to better and more affordable research.


Equipping researchers with all innovative tools, technologies, and expertise can help them achieve their end goal faster and inspire new ways of thinking that can lead to major breakthroughs. Science Exchange empowers researchers, in part, by making all innovative resources readily accessible on the marketplace. Below is a small selection of handpicked services we recently made available on Science Exchange. Ready to start reading? Sit back, relax, and Take 5.


Easi-CRISPR Technology

This novel gene-editing technology by Taconic supports the specific insertion of large segments of exogenous DNA, generating knock-in mice for some applications much more efficiently than CRISPR or standard gene targeting methods.



AI-Powered Immunoinformatics Service

This immunoinformatics service by aiNET analyzes big data, leveraging artificial intelligence technology to select large molecules that bind to cancer, infectious, and autoimmune targets.


Patient-Matched Cytotoxic T Lymphocyte and Tumor Cell Lines

Patient-Matched Cytotoxic T Lymphocyte and Tumor Cell Lines

Researchers can evaluate the efficacy of drug candidates in a KEYTRUDA-resistant tumor through Avicentrix, a novel provider with unique access to HLA-matched cell lines.


ArrayBridge Protein Conformational Array

Protein Conformational Arrays

This recently developed technology can be used to easily characterize the higher order structure of a protein therapeutic or other biologics. Sensitive, quantitative, and systematic, this analysis is useful for cell line development, formulations, and bioprocess optimization.


KaL Model for Epilepsy

This novel animal model of temporal lobe epilepsy, generated using application of both kainic acid and lorazepam, shows improved correlation to human disease compared to traditional animal models of epilepsy.



Gursatya "Guru" Singh

Director of Scientific Content & Marketing

Gursatya Singh, also known as "Guru", manages the development and execution of strategic marketing initiatives to improve platform providers’ visibility and user experience. He is a true guru when it comes to helping providers better advertise their research services and providing buyers with easy access to recently commercialized external innovations. Whether working as a lab researcher, publishing scientific papers, or helping start life science startups, Guru believes in making the scientific world more collaborative and connected. Guru holds a master’s degree in biotechnology from the University of Delaware. Follow him on Twitter @Gursatya.

Leave a Reply

Your email address will not be published.